Beta
356023

Developing a magnetite/mesoporous silica core /shell system for enhancing the anti-cancer performance of Doxorubicin at low doses for breast cancer treatment

Article

Last updated: 30 Dec 2024

Subjects

-

Tags

Nano-materials in cancer therapy

Abstract

Doxorubicin (DOX) as one of the main chemotherapies used in breast cancer in the form of many dosage forms such as encapsulation within pegylated liposomes and by injection. Both dosage forms have several side effects, most importantly dilated cardiomyopathy, erythema, acral erythema, and others. Also, DOX acquires resistance in dose-dependent manner by time. Consequently, there is an urgent need for novel approaches and strategies to improve current chemotherapeutic agents' delivery systems including DOX. Nanoparticles (NPs) have found their way in almost all aspects of biomedical applications within the last two decades, such as medical diagnostics, imaging, and drug/gene delivery systems. Mesoporous silica NPs are of great interest as an efficient drug/gene delivery system due to their unique properties. In the same context, magnetic nanoparticles contributed significantly to biomedicine, for their apparent features emerging at the nanoscale. Core/shell nanoparticles have potential characteristics as they incorporate the multiple merits of the used nanoparticles. Herein, we have developed multifunctional iron oxide/mesoporous silica/amino; core/shell (M/silica/Amino), by sonochemical method, loaded with DOX as a Drug Delivery System (DDS) for breast cancer treatment.

DOI

10.21608/jcbr.2024.236764.1315

Keywords

Doxorubicin (DOX), iron oxide/mesoporous silica/amino core/shell (M@silica@Amino), Drug delivery system, and breast cancer, cell lines

Authors

First Name

Hoor

Last Name

Azab

MiddleName

Mohamed

Affiliation

Chemistry Department Faculty of Science, Tanta University

Email

hoormohamed437@gmail.com

City

-

Orcid

-

First Name

Sherif

Last Name

Shawky

MiddleName

M

Affiliation

Misr University for Science and Technology, Egypt

Email

sshawky@zewailcity.edu.eg

City

Cairo

Orcid

-

First Name

Mohamed

Last Name

El-Sheikh

MiddleName

M

Affiliation

Chemistry Department Faculty of Science, Tanta University

Email

mohamed.youssry@science.tanta.edu.eg

City

Cairo

Orcid

-

First Name

El-Zeiny

Last Name

Ebeid

MiddleName

M

Affiliation

Chemistry Department Faculty of Science, Tanta University

Email

elzeiny.ebeid@science.tanta.edu.eg

City

Cairo

Orcid

-

First Name

Abdelhamid

Last Name

abd-elhamid

MiddleName

-

Affiliation

chemistry department, faculty of science, Tanta University

Email

abdelhamid.elsawy@science.tanta.edu

City

cairo

Orcid

-

First Name

sally

Last Name

shalaby

MiddleName

-

Affiliation

Medical Biochemistry Department, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt

Email

sallyshalaby@hotmail.com

City

-

Orcid

-

First Name

Amal

Last Name

Elshal

MiddleName

-

Affiliation

Medical Biochemistry Department, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt

Email

amalelshal@gmail.com

City

-

Orcid

-

Volume

8

Article Issue

2

Related Issue

47868

Issue Date

2024-06-01

Receive Date

2023-09-16

Publish Date

2024-06-01

Page Start

1

Page End

14

Print ISSN

3009-6391

Online ISSN

3009-7312

Link

https://jcbr.journals.ekb.eg/article_356023.html

Detail API

https://jcbr.journals.ekb.eg/service?article_code=356023

Order

356,023

Type

Original Article

Type Code

885

Publication Type

Journal

Publication Title

Egyptian Journal of Cancer and Biomedical Research

Publication Link

https://jcbr.journals.ekb.eg/

MainTitle

Developing a magnetite/mesoporous silica core /shell system for enhancing the anti-cancer performance of Doxorubicin at low doses for breast cancer treatment

Details

Type

Article

Created At

30 Dec 2024